This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Donsante A, Vogler C, Muzyczka N et al. (2001) Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther 8: 1343–1346
Dummer R, Bergh J, Karlsson Y et al. (2000) Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors. Cancer Gene Ther 7: 1069–1076
Dummer R, Davis-Daneshfar A: Dohring C et al. (1995) Strategien zur Gentherapie des Melanoms. Hautarzt 46: 305–308
Grote D, Russell SJ, Cornu TI et al. (2001) Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97: 3746–3754
Hemmi S, Geertsen R, Mezzacasa A et al. (1998) The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther 9: 2363–2373
Ponnazhagan S, Curiel DT, Shaw DR et al. (2001) Adeno-associated virus for cancer gene therapy. Cancer Res 61: 6313–6321
Puisieux I, Odin L, Poujol D et al. (1998) Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity. Hum Gene Ther 9: 2481–2492
Raj K, Ogston P, Beard P (2001) Virus-mediated killing of cells that lack p53 activity. Nature 412: 914–917
Rochlitz CF (2001) Gene therapy of cancer. Schweiz Med Wochenschr 131: 4–9
Rosenberg SA, Yang JC, Restifo NP (2004) Cancer Immunotherapy: moving beyond current vaccines. Nat. med. 10: 909–15
Schadendorf D, Ugurel S, Schuler-Thurner B (2006) Dacarbacine (DTIC) versus vaccination with antologous peptide-pulsed dendritic cells (DC) in the first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCoG. Ann Oncol 17: 563–70
Slos P, De Meyer M, Leroy P et al. (2001) Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity. Cancer Gene Ther 8: 321–332
Verma IM, Somia N (1997) Gene therapy-promises, problems and prospects. Nature 389: 239–242
Vogelstein B, Kinzler KW (2001) Achilles’ heel of cancer? Nature 412: 865–866
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Dummer, R., Schadendorf, D. (2006). Vakzinierungstrategien mit Hilfe der Gentherapie. In: Management des Melanoms. Onkologie aktuell. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-28988-7_26
Download citation
DOI: https://doi.org/10.1007/3-540-28988-7_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28987-6
Online ISBN: 978-3-540-28988-3
eBook Packages: Medicine (German Language)